Coventry University Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Exeter Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Cardiff University Featured PhD Programmes

MicroRNA dysregulation in malignant germ cell tumours: more than a biomarker?

  • Full or part time
  • Application Deadline
    Wednesday, January 01, 2020
  • Competition Funded PhD Project (European/UK Students Only)
    Competition Funded PhD Project (European/UK Students Only)

Project Description

Malignant germ cell tumours (mGCTs) are clinico-pathologically heterogeneous tumours that are the most common cause of cancer deaths in young adult males. In 2010, we identified changes in microRNA expression levels that were seen in all malignant GCTs, regardless of patient age, tumour site or histologic subtype. The most significant were co-ordinate over-expression of the oncogenic miR-371~373 and miR-302/367 clusters and under-expression of the tumour suppressors miR-99a/100 and miR-125b (see Figure). Multiple international studies have confirmed our findings that quantification of serum levels of miR-371~373 and miR-302/367 microRNA improve mGCT diagnosis. It is widely predicted that this approach will enter routine clinical use world-wide in the next 2-3 years. The current project will test the hypothesis that the dysregulated microRNAs represent important therapeutic targets in mGCTs. Many of the microRNAs share the same functional ‘seed’ at nt 2-7, leading to deregulation of mRNA targets and recapitulation of a stem cell phenotype. The project will use inducible systems for in vivo manipulation of microRNA levels in a panel of luciferase-labelled mGCT cell lines representing all major histological types. We have generated tetracycline-inducible lentiviral vectors for increasing expression levels of miR-99a/100 and 125b, either singly or in combination, and will derive inducible shRNA vectors for reducing levels of miR-371~373/miR-302/367. After in vitro characterisation, the student will quantify the effects of inducing tumour suppressor microRNAs and/or depleting oncogenic microRNAs on established subcutaneous, testicular orthotopic and metastatic lung tumours in nude mice. Readouts will include tumour morphology and mRNA expression profiling, including measurement of direct miRNA effects using the Sylamer algorithm (Enright lab). In due course, the work will be extended using patient-derived xenografts and nanoparticle delivery, with the aim of progressing to first-in-man trials via our collaboration with the Cambridge Clinical Trials Unit.

Funding Notes

Funding* will cover the student’s stipend at the current Research Council rate and University Fees. The studentships will be funded for three years in the first instance subject to eligibility**, with the possibility of additional funding in the fourth year depending on circumstances.

**The studentships are available to students who qualify for Home/EU fees

Applications from ineligible candidates will not be considered.

(View Website)

The University values diversity and is committed to equality of opportunity.

The University has a responsibility to ensure that all employees are eligible to live and work in the UK.


1. Murray MJ and Coleman N (2019) MicroRNA dysregulation in malignant germ cell tumours: more than a biomarker? Journal of Clinical Oncology (in press)
2. Kucia-Tran JA, Tulkki V, Scarpini CG, Smith S, Wallberg M, Paez-Ribes M, Araujo AM, Botthoff J, Feeney M, Hughes K, Caffarel MM, Coleman N. (2018) Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma. The Journal of Pathology 244: 283-295
3. Murray MJ, Watson HL, Ward D, Bailey S, Ferraresso M, Nicholson JC, Gnanapragasam VJ, Thomas B, Scarpini CG, Coleman N. (2017) ‘Future-proofing’ blood processing for measurement of circulating microRNAs in samples from biobanks and prospective clinical trials. Cancer Epidemiology, Biomarkers and Prevention 27:208-218

Related Subjects

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2019
All rights reserved.